Cancer phototherapy with nano-bacteria biohybrids.


Journal

Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908

Informations de publication

Date de publication:
08 2023
Historique:
received: 24 03 2023
revised: 24 05 2023
accepted: 03 06 2023
medline: 21 8 2023
pubmed: 15 6 2023
entrez: 14 6 2023
Statut: ppublish

Résumé

The utilization of light for therapeutic interventions, also known as phototherapy, has been extensively employed in the treatment of a wide range of illnesses, including cancer. Despite the benefits of its non-invasive nature, phototherapy still faces challenges pertaining to the delivery of phototherapeutic agents, phototoxicity, and light delivery. The incorporation of nanomaterials and bacteria in phototherapy has emerged as a promising approach that leverages the unique properties of each component. The resulting nano-bacteria biohybrids exhibit enhanced therapeutic efficacy when compared to either component individually. In this review, we summarize and discuss the various strategies for assembling nano-bacteria biohybrids and their applications in phototherapy. We provide a comprehensive overview of the properties and functionalities of nanomaterials and cells in the biohybrids. Notably, we highlight the roles of bacteria beyond their function as drug vehicles, particularly their capacity to produce bioactive molecules. Despite being in its early stage, the integration of photoelectric nanomaterials and genetically engineered bacteria holds promise as an effective biosystem for antitumor phototherapy. The utilization of nano-bacteria biohybrids in phototherapy is a promising avenue for future investigation, with the potential to enhance treatment outcomes for cancer patients.

Identifiants

pubmed: 37315693
pii: S0168-3659(23)00379-6
doi: 10.1016/j.jconrel.2023.06.009
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-148

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Hongfei Lu (H)

Department of Chemical and Environmental Engineering, Shanghai University, Shanghai 200433, China.

Luqi Niu (L)

Department of Chemical and Environmental Engineering, Shanghai University, Shanghai 200433, China.

Lin Yu (L)

School of Medicine, Shanghai University, Shanghai 200433, China.

Kai Jin (K)

Department of Chemical and Environmental Engineering, Shanghai University, Shanghai 200433, China.

Jing Zhang (J)

Department of Chemical and Environmental Engineering, Shanghai University, Shanghai 200433, China.

Jinliang Liu (J)

Department of Chemical and Environmental Engineering, Shanghai University, Shanghai 200433, China.

Xiaohui Zhu (X)

Department of Chemical and Environmental Engineering, Shanghai University, Shanghai 200433, China.

Yihan Wu (Y)

Department of Chemical and Environmental Engineering, Shanghai University, Shanghai 200433, China. Electronic address: yihanw@shu.edu.cn.

Yong Zhang (Y)

Department of Biomedical Engineering, National University of Singapore, 119077, Singapore; National University of Singapore Research Institute, Suzhou 215123, Jiangsu, China. Electronic address: biezy@nus.edu.sg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH